RT Journal Article
SR Electronic
T1 Predicting Long-term Evolution of COVID-19 by On-going Data using Bayesian Susceptible-Infected-Removed Model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.08.20094953
DO 10.1101/2020.05.08.20094953
A1 Hidaka, Shohei
A1 Torii, Takuma
YR 2020
UL http://medrxiv.org/content/early/2020/05/12/2020.05.08.20094953.abstract
AB In this study, we propose a novel statistical method to predict a long-term epidemic evolution based on a on-going data. We developed a Bayesian framework for the Susceptible-Infected-Removed model (Bayesian SIR), and estimated its underlying parameters based on day-by-day timeseries of the cumulative number of infectious individuals. The new Baysian framework extends the deterministic SIR model to a probabilistic form, which provides an accurate estimation of the underlying system by a short and noisy data. We applied it to the data reported on the Coronavirus Disease 2019 (COVID-19), and made a month long prediction on its evolution. Our simulated test using past timeseries to predict the current data gives a reasonable reliablity of the proposed method. Our analysis of the current data detected and warned a rising trend in the countries in Central Asia, Middle East, and South America, while United States or European countries, which have already experienced large numbers of infected cases, are predicted to slow down in the increase.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding is received for this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study uses the data repository provided by Johns Hopkins CSSE accessed on April 23rd in 2020. https://github.com/CSSEGISandData/COVID-19